| |
The 6th Edition is in stock!
Pay on-line for
a single book with Quick Pay, or see How To Order for more info.
News on the UroAnki Deck
Intel Dinar Chronicles Blogspot Best
| Aspect | Evaluation | Reasoning |
|--------|------------|-----------|
| Author identity | Unclear | No verifiable credentials; the author uses a pseudonym and provides no professional background. |
| Citations | Sparse | Most posts rely on anecdotal “insider tips” and vague references to “official statements” without linking to primary documents (e.g., Central Bank of Iraq releases). |
| Fact‑checking | Low | Claims such as “the dinar will reach 10 USD per unit within 12 months” are not supported by macro‑economic data or reputable financial analysis. |
| Transparency | Limited | The blog does not disclose any affiliations, sponsorships, or potential conflicts of interest. |
Bottom line: The site’s credibility is weak; readers should treat its predictions as speculative and verify any investment advice with independent, reputable sources.
The "Intel Providers" are the lifeblood of the site. They rarely provide verifiable proof. Instead, they rely on "sources in the know"—alleged contacts in the U.S. Treasury, the Iraqi Parliament, or international banking sectors. Because the sources are anonymous, their claims are unfalsifiable by the average reader. intel dinar chronicles blogspot best
If you read the blog, you will notice repetitive patterns in the content:
Before we declare it the "best," we need to define the beast. The Intel Dinar Chronicles (often hosted on the Blogspot/Blogger platform due to its resilience against censorship) is not a mainstream financial outlet. You won't find it on Bloomberg or Reuters. The "Intel Providers" are the lifeblood of the site
Instead, it is a aggregate blog. It compiles "intelligence" (intel) from various sources—self-proclaimed "Gurus," currency specialists, military insiders, and financial whistleblowers—regarding the status of the Iraqi Dinar, the Vietnamese Dong, and the broader "Global Currency Reset" (GCR).
The Intel Dinar Chronicles represents a fascinating case study in modern information consumption and financial psychology. It is a "best-in-class" example of a community built on hope, faith, and alternative media. the Iraqi Parliament
For the faithful, the blog is a beacon of light offering daily affirmation that their financial salvation is just around the corner. To the skeptic, it is a "hopium" dispenser—providing endless justifications for why a promised financial windfall has yet to arrive.
Whether viewed as a harmless hobby, a spiritual journey, or a predatory trap, the blog highlights a critical truth: in times of economic uncertainty, people will always seek out narratives that promise a better tomorrow, regardless of whether those narratives align with Wall Street reality.
Info on 6 edition: The 6th edition is available in print form. The
6th edition is 150 pages longer then the previous edition. It now has
754 pages of urology content. The book became too thick to be managed
effectively as a single volume using a spiral binding. So, the book has been separated into 2 volumes: oncology and non-oncology (each volume is spiral bound). When you purchase the book, you receive volumes 1 & 2 (the volumes are not sold separately).
There
are no new chapters, but here have been updates/additions to almost
every chapter. For a brief list of the updates, see below.
The
Pocket
Guide to Urology - 6th Edition
Since
the first edition
was released in
1999, the Pocket Guide to Urology has become one of the most popular
urology texts. Nearly 50,000 copies of the Pocket Guide to Urology have
been
printed and
distributed worldwide (over 50 countries on 6 continents). The 6th
edition is currently for sale.
The 6th edition of the Pocket
Guide
to Urology is a comprehensive evidence-based reference book that
emphasizes
clinical guidelines, consensus statements, and landmark
studies. Information
is compiled and is
presented in a thorough, organized, and logical format.
Each chapter contains detailed references.
The 6th edition of the Pocket
Guide to Urology contains a plethora of new information (see what is new).
It has 754
pages and contains the following
chapters:


|
|
|
Contents
Renal
Tumors
Wilms’ Tumor
& Other Pediatric Renal Tumors
Bladder Tumors
Upper Tract Urothelial Tumors
Tumor Markers for Urothelial Cancer
Penile
Tumors
Testicular Tumors
Prostate Cancer
Androgen
Deprivation
Prostate
Specific Antigen (PSA)
Voiding
& Urodynamics
Benign
Prostatic
Hyperplasia
Urinary
Incontinence: General Concepts
Urge Incontinence &
Overactive Bladder
Stress Incontinence in the Female
Stress
Incontinence in the Male
Hematuria
Urolithiasis
Strictures of the Lower Urinary Tract
Strictures
of the Upper Urinary
Tract
Imaging
& Radiology
Embryology
Pregnancy:
Urologic
Considerations
Vesicoureteral
Reflux (VUR)
Erectile
Dysfunction (ED)
Male Hypogonadism
Ejaculatory
Disorders
Male
Infertility
Emergent
Urologic Conditions
Priapism
Genitourinary
Trauma
Genitourinary
Infections: General Concepts
Lower Urinary Tract Infections
Upper
Urinary Tract Infections
Genital Infections
Prostatitis
& Prostate Infections
Sexually
Transmitted Diseases
Gas
Forming Infections
Fungal Infections
Malacoplakia
&
Tuberculosis
Surgical
Principles for the
Urologist
Ureteral Stents
Use of Intestine in the
Urinary
Tract
Doses of Commonly
Used
Medications
Formulas and Conversions |
|
|
|
Updates in the 6th Edition
Updates/additions to the 6th edition include:
● NCCN - 2021 guidelines
● AUA - most recent guidelines
● EAU - 2021 guidelines
● Many other recent guidelines including CDC, WHO, Infectious Diseases Society of America (ISDA),
American Association for the Surgery of Trauma (AAST), American College
of Radiology (ACR),
European Society of Urogenital Radiology, American College of
Obstetricans and Gynecologists,
International Continence Society (ICS), etc.
● Updates and addition of landmark studies.
● New medications: Jatenzo, Vibegron, Lumasiran, Relugolix, jelmyto,
PARP inhibitors (Olaparib, Rucaparib),
PDL/PDL1 inhibitors (Pembrolizumab, Erdafitinib), etc.
● Updates of all flowsheets and diagrams to reflect the most recent
guidelines and data.
● Update on Bozniak classifiation
● PET/CT information including flucyclovine and PSMA.
● Expanded section on MRI, including MRI guided prostate biopsy, MRI for cancer surveillance, etc.
● Expanded on genetic risks for the various cancers, somatic & germline tests, and testing guidelines.
● More info on molecular testing for prostate cancer: decipher, oncotype dx, prolaris, etc.
● Newest studies on salvage and adjuvant XRT after RP for prostate cancer
● Newer BPH treatments (acquablation, resume, etc).
● Updates and additions to almost every chapter.
Pocket
Guide to
Urology, Sixth Edition - Copyright 2021 by Jeff A. Wieder.
All rights reserved.
This website was last updated May 2, 2026.
|
|